Pfizer Inc. et al v. Zenara Pharma Private Limited
| Wyeth LLC, PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC and Pfizer Inc. |
| Zenara Pharma Private Limited |
| 1:2026cv01402 |
| October 29, 2026 |
| U.S. District Court for the District of Delaware |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
This docket was last retrieved on October 30, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 6 Summons Issued as to Zenara Pharma Private Limited on 10/30/2026. (aas) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Wyeth LLC filed by FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V., Pfizer Inc., Wyeth LLC. (aas) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,770,441 B2. (aas) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 15, 2026. Date of Expiration of Patent: August 31, 2035.Thirty Month Stay Deadline: 3/15/2029. (aas) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aas) |
| Filing 1 COMPLAINT against Zenara Pharma Private Limited (Filing fee $ 405, receipt number ADEDC-5101310) - filed by PF PRISM IMB B.V., FoldRx Pharmaceuticals, LLC, Wyeth LLC, Pfizer Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(aas) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.